key: cord-0968603-llclady6
authors: Parcha, Vibhu; Malla, Gargya; Suri, Sarabjeet S.; Kalra, Rajat; Heindl, Brittain; Berra, Lorenzo; Fouad, Mona N.; Arora, Garima; Arora, Pankaj
title: Geographic Variation of Racial Disparities in Health and COVID-19 Mortality
date: 2020-10-06
journal: Mayo Clin Proc Innov Qual Outcomes
DOI: 10.1016/j.mayocpiqo.2020.09.005
sha: 16edb7092a3663df1b8a1cba119b5216ebd7c257
doc_id: 968603
cord_uid: llclady6

Objective To evaluate the race-stratified state-level prevalence of health determinants and the racial disparities in coronavirus disease-2019 (COVID-19) cumulative incidence and mortality in the United States. Patients and Methods Age-adjusted race-stratified prevalence of comorbidities (hypertension, diabetes, dyslipidemia, obesity), preexisting medical conditions (pulmonary disease, heart disease, stroke, kidney disease, malignancy), poor health behaviors (smoking, alcohol abuse, physical inactivity), and adverse socioeconomic factors (education, household income, health insurance) was computed in 435,139 American adult participants from 2017 Behavioral Risk Factor Surveillance System survey (BRFSS). Correlation was assessed between health determinants and the race-stratified COVID-19 crude mortality and infection-fatality-ratio computed from respective state public health departments in 47 states. Results Blacks had a higher prevalence of comorbidities (63.3% [95%CI:62.4-64.2%] vs. 55.1% [95%CI:54.7-55.5]) and adverse socioeconomic factors (47.0% [95%CI:46.0-47.9%] vs. 30.9% [95%CI:30.6-31.3]) than Whites. The prevalence of preexisting medical conditions was similar among Blacks (30.4% [95%CI:28.8-32.1%]) and Whites (30.8% [95%CI:30.2-31.4%]). The prevalence of poor health behaviors was higher in Whites (57.2% [95%CI:56.3-58.0%]) than Blacks (50.2% [95%CI:46.2-54.2%]). The comorbidities and adverse socioeconomic factors were highest in the Southern region, and poor health behaviors were highest in the Western region. Cumulative incidence rate (per 100,000 persons) was three-fold higher in Blacks (1546.4) compared withwith Whites (540.4). The crude mortality (per 100,000 persons) was two-fold higher in Blacks (83.2) than Whites (33.2). However, the infection-fatality-ratio (per 100-cases) was similar between Whites (6.2) and Blacks (5.4). Within racial groups, the geographic distribution of health determinants did not correlate with state-level COVID-19 mortality and infection-fatality ratio (p>0.05 for all). Conclusions Racial disparities in COVID-19 are largely driven by the higher cumulative incidence of infection in Blacks. There is a discordance between the geographic dispersion of COVID-19 mortality and the regional distribution of health determinants.

We included 435,139 individuals from the 2017 BRFSS survey cycle, where selfreported data on race was available. The demographic distribution and socioeconomic measures of the study population across the census regions for the respective racial groups are described in eTable 1.

Nationally, the prevalence of >1 comorbidity (any of diabetes, hypertension, hypercholesterolemia, and obesity) was 63.3% (95%CI:62. 4 

The prevalence of >1 preexisting medical condition (any of pulmonary disease, malignancy, kidney disease, or cardiac disease) was 28 

Nationally, the prevalence of >1 poor health behaviors (any of alcohol abuse, current smoking, or physical inactivity) was 53.2% (95%CI:52. 2 

The prevalence of >1 adverse socioeconomic factors (any of lack of health insurance, low annual household income, or less than high school education) nationally was 47 

In the states reporting race-stratified data, there were total 623,177 COVID- 19 persons) was over two times higher than among Whites (33.2 per 100,000 persons). The IFR in J o u r n a l P r e -p r o o f

In this study, we observed that the prevalence of comorbidities and adverse socioeconomic factors was higher among Black individuals, and these determinants were concentrated in Southern and Midwestern American states for both Black and White individuals.

Substantial geographic heterogeneity in the prevalence of clinical and social determinants of health was noted within the racial groups. In states reporting race stratified data on COVID-19 cases and mortality, the COVID-19 cumulative incidence rate was nearly three-folds higher, and the COVID-19 mortality was over two-fold higher in Black individuals compared to their White counterparts. Notably, the IFR between Black individuals and White individuals was similar across all the states with available data. While the pernicious influence of comorbidities and adverse socioeconomic factors may explain the higher proportion of COVID-19 infections and mortality burden in Black individuals, the known health determinants did not track with the current geographic pattern of COVID-19 fatality within the racial groups.

We demonstrated a greater prevalence of comorbidities among Black individuals universally across the American states, with a considerably higher concentration of comorbidities in the Southern and Midwestern regions. While the prevalence of preexisting medical conditions was comparable between racial groups, White individuals had a higher prevalence of poor health behaviors. There are inherent differences in the geographic distribution of these biological determinants within the Black and White racial groups. A higher prevalence of comorbidities has been previously reported in the deep south, which is often attributed to the higher proportion of Black individuals and clustering of the socioeconomic factors in the region. 16, [19] [20] [21] [22] We substantiate these reports and provide perspective into these regional differences by highlighting J o u r n a l P r e -p r o o f 14 that both Blacks and Whites in the Southern region have a higher comorbidity burden compared with their counterparts in the rest of the U.S.

The population-level COVID-19 mortality burden is presumed to follow the population prevalence of comorbidities given that comorbidity burden and concomitant illnesses are critical factors in predicting the risk of fatal outcomes from COVID-19 in inpatient settings. [23] [24] [25] [26] [27] [28] [29] [30] However, our investigation indicates that within the racial groups, the greater comorbidity burden does not track with geographic dispersion of COVID-19 fatality. While Black individuals are evidently at a greater risk of getting COVID-19 and bearing a greater mortality burden, once they get the disease, they may be deemed to be at a similar risk as their White counterparts. This is evident in the higher population-level COVID-19 mortality burden in Blacks but having a similar or lower IFR as Whites. Our ecological investigation aligns with the clinical reports from inpatient settings, wherein the risk of COVID-19 mortality is similar between Black and White patients after adjusting the clinical and socioeconomic health determinants. 31 There may be other plausible biological and environmental factors governing the severity and fatality from the novel and ubiquitous virus above and beyond the population prevalence of comorbidities. 32, 33 Racial disparities in exposure, susceptibility, and mortality due to a respiratory viral pandemic have been previously reported during the H1N1 pandemic. 34, 35 While the impact of a higher prevalence of comorbidities in Black individuals increases their susceptibility to severe infection and adverse outcomes, the malignant impact of adverse socioeconomic determinants of health is heightened during the pandemic. 34-38 Numerous adverse socioeconomic factors prevent the at-risk Black population from assiduously adhering to social distancing measures. 1-4, 38, 39 Disproportionately higher numbers of Blacks are socioeconomically restricted and are prone to J o u r n a l P r e -p r o o f COVID-19 exposure due to increased housing density, crowded living conditions, reduced ability to work from home or endure long unpaid furloughs, dependence on public transportation, and decreased access to healthy food. 1-4, 38, 39 Racial minorities also make up the majority of the workforce in areas such as healthcare, government, transportation, and food supply that are deemed as essential services. 1-4, 38, 39 The socioeconomic constraints affecting the high-risk Black population presents a vexing challenge to the adequate implementation of preventive measures. 1-4, 38, 39 However, the racial impact of these determinants may be attenuated once individuals are infected.

We noted that a lack of health insurance coverage was more prevalent among Black individuals in all American states. Lack of access to healthcare is a critical factor that impedes minority groups from seeking medical attention for symptoms. Early in the pandemic, limited testing capacity for COVID-19 led to a requirement that referral from healthcare workers was necessary to be tested. Those without health insurance were less likely to seek physician consultation, rendering them undiagnosed with possible COVID-19 infection, and a source of potential viral spread within the community. Additionally, the nationwide response to the pandemic has varied due to the differential burden of COVID-19 across states and the heterogeneity in the responses of local public health agencies. 5, 6 The complex equipoise of the various factors may explain the geographic mismatch in the risk factor prevalence and COVID-19 fatality within the racial groups.

Our study has crucial public health implications by contextualizing the racial disparities seen with COVID-19. The persistent racial disparities in healthcare, as underlined by our study, may predispose Black individuals to bear the hefty share of the COVID-19 pandemic. Within race, individuals are at a higher COVID-19 risk, notwithstanding the population prevalence of J o u r n a l P r e -p r o o f comorbidities and socioeconomic factors. The observed racial differences in COVID-19 cumulative incidence and mortality may be due to variation in the physical environment, health behaviors, access to clinical care, low penetration of evidence-based treatment strategies, social discrimination, poor socioeconomic status, and education, which will continue to persist, if not increase, after the impact of the ongoing pandemic. 20, [40] [41] [42] [43] [44] [45] [46] [47] Our data call for the prioritization of public health initiatives explicitly targeted at minority populations with region-specific approaches to stem these disparities. The COVID-19 cumulative incidence and mortality do not conform to the geographic distribution of health and social determinants, which is worrisome and indicate that other modulating factors need to be explored. The economic recession secondary to the pandemic may disproportionately affect racial minorities, with more people losing health insurance coverage and further worsening of the preexisting medical conditions. The relaxation of social distancing may critically impact racial minorities who are already at a higher risk for adverse outcomes due to a large comorbidity burden, unemployment, food insecurity, and limited access to healthcare. Such conditions may perpetuate the deeply entrenched racial disparities in health outcomes 48, 49 and make the mitigation of these disparities even more challenging.

Our investigation may have several limitations. The BRFSS includes self-reported crosssectional survey data from which true disease incidence cannot be discerned. However, BRFSS data have been previously validated in numerous studies. 8, 9 The small population size of other racial sub-groups at the state-level lead to unreliable estimates, restricted their inclusion in the study. Moreover, due to several incongruences, lack of uniformity, and large missing data, in the reporting of race-stratified COVID-19 cumulative incidence and mortality reported by respective states, prevented us from making a uniform assessment. Mortality due to COVID-19 has been J o u r n a l P r e -p r o o f assessed as both at population-level (per 100,000 individuals in the area), and at the case-level (IFR). We report both the mortality metrics that quantify the population mortality burden (crude mortality rate) and case-associated fatality (IFR). The COVID-19 pandemic is ongoing and at various stages in different states, and the current mortality statistics provide only a cross- The darker shades represent higher prevalence, and lighter shades represent lower prevalence.

Age-adjusted prevalence is reported along with 95% confidence intervals. J o u r n a l P r e -p r o o f

The BRFSS was used to quantify state-level health behaviors and risk factors. 13 The BRFSS is one of the largest continuously conducted health-related surveys, collecting data from over 400,000 American adults annually. 13 The respective state public health department databases were used to quantify the race-stratified COVID-19 cases and mortality. The latest state-level population data were obtained from the U.S. Census Bureau. 14

All American adults ≥18 years of age who participated in the 2017 BRFSS were included in the study. The data regarding all health determinants were obtained from participants from all fifty states and Washington D.C. and included in this study. Pregnant females and those with missing data were excluded from the analyses. The exclusion of pregnant women was done due to difficulty in attributing the various health measures as being a chronic condition or being associated with pregnancy only. The mortality analyses included data from residents from the 47 states that are reporting race-stratified COVID-19 cases and mortality.

The self-reported race from each respondent was used to stratify them as either White or The cumulative incidence rate, crude mortality rate, and IFR was computed for those states reporting race-stratified COVID-19 cases and deaths, reported until August 16, 2020.

All statistical analyses were done using the survey procedures in SAS 9.4 (S.A.S.

Institute Inc., Cary, N.C) to account for the intricate stratified survey sampling design. 15 The national, regional, and state-level population estimates were generated using sample weights to account for participant non-response and non-coverage in the sample design. 16 American Community Survey were used to compute the crude mortality rate. 18 The IFR was computed as the number of deaths per 100 confirmed cases of COVID-19 in respective states.

We assessed the correlation (Pearson correlation) of the race-stratified state-level crude mortality rate, and IFR, and the state-level, race-stratified, prevalence of various health determinants. The correlation of the COVID-19 measures with health determinants was assessed, taking the health determinants in the pre-specified groups (comorbidities, preexisting medical conditions, poor health behaviors, and adverse socioeconomic factors).

We included 435,139 individuals from the 2017 BRFSS survey cycle, where selfreported data on race was available. The demographic distribution and socioeconomic measures of the study population across the census regions for the respective racial groups are described in eTable 1. 

The prevalence of >1 adverse socioeconomic factors (any of lack of health insurance, low annual household income, or less than high school education) nationally was 47 

In the states reporting race-stratified data, there were total 623,177 COVID-19 cases persons) was over two times higher than among Whites (33.2 per 100,000 persons). The IFR in J o u r n a l P r e -p r o o f significant correlation between the state-level race-stratified crude mortality and IFR with the prevalence of comorbidities, preexisting medical conditions, poor health behaviors, and adverse socioeconomic factors (Figure 2-4, eFigure 1-2) .

In this study, we observed that the prevalence of comorbidities and adverse socioeconomic factors was higher among Black individuals, and these determinants were concentrated in Southern and Midwestern American states for both Black and White individuals.

Substantial geographic heterogeneity in the prevalence of clinical and social determinants of health was noted within the racial groups. In states reporting race stratified data on COVID-19 cases and mortality, the COVID-19 cumulative incidence rate was nearly three-folds higher, and the COVID-19 mortality was over two-fold higher in Black individuals compared to their White counterparts. Notably, the IFR between Black individuals and White individuals was similar across all the states with available data. While the pernicious influence of comorbidities and adverse socioeconomic factors may explain the higher proportion of COVID-19 infections and mortality burden in Black individuals, the known health determinants did not track with the current geographic pattern of COVID-19 fatality within the racial groups.

We demonstrated a greater prevalence of comorbidities among Black individuals universally across the American states, with a considerably higher concentration of comorbidities in the Southern and Midwestern regions. While the prevalence of preexisting medical conditions was comparable between racial groups, White individuals had a higher prevalence of poor health behaviors. There are inherent differences in the geographic distribution of these biological determinants within the Black and White racial groups. A higher prevalence of comorbidities has been previously reported in the deep south, which is often attributed to the higher proportion of Black individuals and clustering of the socioeconomic factors in the region. 16, [19] [20] [21] [22] We substantiate these reports and provide perspective into these regional differences by highlighting J o u r n a l P r e -p r o o f 13 that both Blacks and Whites in the Southern region have a higher comorbidity burden compared with their counterparts in the rest of the U.S.

The population-level COVID-19 mortality burden is presumed to follow the population prevalence of comorbidities given that comorbidity burden and concomitant illnesses are critical factors in predicting the risk of fatal outcomes from COVID-19 in inpatient settings. [23] [24] [25] [26] [27] [28] [29] [30] However, our investigation indicates that within the racial groups, the greater comorbidity burden does not track with geographic dispersion of COVID-19 fatality. While Black individuals are evidently at a greater risk of getting COVID-19 and bearing a greater mortality burden, once they get the disease, they may be deemed to be at a similar risk as their White counterparts. This is evident in the higher population-level COVID-19 mortality burden in Blacks but having a similar or lower IFR as Whites. Our ecological investigation aligns with the clinical reports from inpatient settings, wherein the risk of COVID-19 mortality is similar between Black and White patients after adjusting the clinical and socioeconomic health determinants. 31 There may be other plausible biological and environmental factors governing the severity and fatality from the novel and ubiquitous virus above and beyond the population prevalence of comorbidities. 32, 33 Racial disparities in exposure, susceptibility, and mortality due to a respiratory viral pandemic have been previously reported during the H1N1 pandemic. 34, 35 While the impact of a higher prevalence of comorbidities in Black individuals increases their susceptibility to severe infection and adverse outcomes, the malignant impact of adverse socioeconomic determinants of health is heightened during the pandemic. 34-38 Numerous adverse socioeconomic factors prevent the at-risk Black population from assiduously adhering to social distancing measures. 1-4, 38, 39 Disproportionately higher numbers of Blacks are socioeconomically restricted and are prone to J o u r n a l P r e -p r o o f COVID-19 exposure due to increased housing density, crowded living conditions, reduced ability to work from home or endure long unpaid furloughs, dependence on public transportation, and decreased access to healthy food. 1-4, 38, 39 Racial minorities also make up the majority of the workforce in areas such as healthcare, government, transportation, and food supply that are deemed as essential services. 1-4, 38, 39 The socioeconomic constraints affecting the high-risk Black population presents a vexing challenge to the adequate implementation of preventive measures. 1-4, 38, 39 However, the racial impact of these determinants may be attenuated once individuals are infected.

We noted that a lack of health insurance coverage was more prevalent among Black individuals in all American states. Lack of access to healthcare is a critical factor that impedes minority groups from seeking medical attention for symptoms. Early in the pandemic, limited testing capacity for COVID-19 led to a requirement that referral from healthcare workers was necessary to be tested. Those without health insurance were less likely to seek physician consultation, rendering them undiagnosed with possible COVID-19 infection, and a source of potential viral spread within the community. Additionally, the nationwide response to the pandemic has varied due to the differential burden of COVID-19 across states and the heterogeneity in the responses of local public health agencies. 5, 6 The complex equipoise of the various factors may explain the geographic mismatch in the risk factor prevalence and COVID-19 fatality within the racial groups.

Our study has crucial public health implications by contextualizing the racial disparities seen with COVID-19. The persistent racial disparities in healthcare, as underlined by our study, may predispose Black individuals to bear the hefty share of the COVID-19 pandemic. Within race, individuals are at a higher COVID-19 risk, notwithstanding the population prevalence of cumulative incidence and mortality may be due to variation in the physical environment, health behaviors, access to clinical care, low penetration of evidence-based treatment strategies, social discrimination, poor socioeconomic status, and education, which will continue to persist, if not increase, after the impact of the ongoing pandemic. 20, [40] [41] [42] [43] [44] [45] [46] [47] Our data call for the prioritization of public health initiatives explicitly targeted at minority populations with region-specific approaches to stem these disparities. The COVID-19 cumulative incidence and mortality do not conform to the geographic distribution of health and social determinants, which is worrisome and indicate that other modulating factors need to be explored. The economic recession secondary to the pandemic may disproportionately affect racial minorities, with more people losing health insurance coverage and further worsening of the preexisting medical conditions. The relaxation of social distancing may critically impact racial minorities who are already at a higher risk for adverse outcomes due to a large comorbidity burden, unemployment, food insecurity, and limited access to healthcare. Such conditions may perpetuate the deeply entrenched racial disparities in health outcomes 48, 49 and make the mitigation of these disparities even more challenging.

Our investigation may have several limitations. The BRFSS includes self-reported crosssectional survey data from which true disease incidence cannot be discerned. However, BRFSS data have been previously validated in numerous studies. 8, 9 The small population size of other racial sub-groups at the state-level lead to unreliable estimates, restricted their inclusion in the study. Moreover, due to several incongruences, lack of uniformity, and large missing data, in the reporting of race-stratified COVID-19 cumulative incidence and mortality reported by respective states, prevented us from making a uniform assessment. Mortality due to COVID-19 has been The darker shades represent higher prevalence, and lighter shades represent lower prevalence.

Age-adjusted prevalence is reported along with 95% confidence intervals. Response: We thank the Reviewer for their comments. We clarify the definition of the preexisting medical conditions in the manuscript Supplementary Methods and have corrected the typographical error induced confusion in the row labels presented in Table 1 .

Supplementary Methods, Page 2 "An affirmative response to the question "ever been told that you have chronic obstructive pulmonary disease, emphysema or chronic bronchitis" or "ever been told that you had asthma" was used to identify lung disease." "Participants who responded affirmatively to the question, "Have you ever been told by a doctor, nurse, or other health professionals that you have high blood pressure?" were determined to have hypertension. 2, 3 Diabetes was defined as the current use of insulin or self-reported history of diabetes outside of pregnancy. Individuals who reported having their blood cholesterol evaluated and having been told that they had high blood cholesterol levels were defined as having hypercholesterolemia. 2, 3 As previously validated, body mass index was computed from self-reported height and weight, and those with a body mass idex ≥30 kg/m 2 were deemed obese. [2] [3] [4] An affirmative response to the question "ever been told that you have chronic obstructive pulmonary disease, emphysema or chronic bronchitis" or "ever been told that you had asthma" was used to identify lung disease. Individuals who reported having myocardial infarction/coronary heart disease were described as having cardiac disease. A history of kidney disease was identified in participants who reported being told that they have kidney disease (not including kidney stones, bladder infection, or incontinence). Those who reported having a stroke in the past were described as being individuals with prior stroke. Patients with a positive response to having been told that they had any type of malignancy, including skin cancer, were deemed to be individuals with malignancy.

Current smokers were defined as individuals who currently smoked and had smoked at least 100 cigarettes in their lifetime. 2, 3 Current alcohol abuse was defined as the consumption of >2 drinks a day for men and >1 drink a day for women. Physical inactivity was defined as individuals who were engaged in ≤75 minutes per week of vigorous physical activity or ≤150 minutes per week of moderate-intensity physical activity, as previously described. 2, 3 " Introduction 1. The authors cite two studies in cardiovascular health to assert there is limited state-level and race-stratified contemporary data on various health determinants. This is problematic in that literature on other non-cardiovascular determinants is referenced. In this Reviewer's experience, there is a wide and continually updated body of epidemiological literature on determinants, especially in the areas of comorbidities, poor health behaviors, and SES factors.

We thank the Reviewer for their comments. We agree that while there are separate reports of some of the risk factors (comorbidities, poor health behaviors, and socioeconomic factors), the largest health disparities report by the Centers for Disease Control and Prevention (CDC) was made available in 2013. 5, 6 Since then, there has not been a major update in the statelevel race-stratified data about the comorbidities, poor health behaviors, and socioeconomic factors from a single large nationally and state-level representative database. Moreover, the relationship of these factors with COVID-19 crude mortality and IFR at the population level has not been assessed in a race-stratified manner.

Introduction, Page 4 "There is a heterogeneous geographic distribution of the biological, behavioral, and socioeconomic health determinants in the overall population. 2, 3 However, there are limited contemporary data on the race-stratified, state-level, the prevalence of the various health determinants. 2, 3, 5-7 Data pertaining to comorbidities, preexisting medical conditions, poor health behaviors, and adverse socioeconomic factors may help provide insight into the public health implications of the COVID-19 pandemic, especially among Black individuals." Methods 1. The authors used health determinant data from all 50 states with the 2017 BRFSS but only COVID-19 from 30 states. Sensitivity analyses should be conducted when data of this amount is excluded.

Racial Health Disparities and Covid-19 -Caution and Context

COVID-19 and African Americans

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease

COVID-19 in Racial and Ethnic Minority Groups

Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States

Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak -United States

Outbreak Response Capacity Assessments and Improvements Among Public Health Department Health Care-Associated Infection Programs-United States

Changes in Cardiovascular Health in the United States

Status of cardiovascular health among adult Americans in the 50 States and the District of Columbia

Behavioral Risk Factor Surveillance System (BRFSS)

National and State Estiamtes

Geographic variations in cardiovascular health in the United States: contributions of state-and individual-level factors

Trends in major risk factors for cardiovascular disease among adults in the Mississippi Delta region, Mississippi Behavioral Risk Factor Surveillance System

Clinical Characteristics of Coronavirus Disease 2019 in China

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Racial Health Disparities and Covid-19 -Caution and Context

COVID-19 and African Americans

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease

COVID-19 in Racial and Ethnic Minority Groups

Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States

Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak -United States

Outbreak Response Capacity Assessments and Improvements Among Public Health Department Health Care-Associated Infection Programs-United States

Changes in Cardiovascular Health in the United States

Status of cardiovascular health among adult Americans in the 50 States and the District of Columbia

Racial/Ethnic Health Disparities Among Rural Adults -United States

Conclusion and future directions: C.D.C. Health Disparities and Inequalities Report -United States

Centers for Disease C, Prevention. Introduction: C.D.C. Health Disparities and Inequalities Report -United States

Behavioral Risk Factor Surveillance System (BRFSS)

Treasure Island (FL)

United States Census Bureau. 2019 National and State Estiamtes. Accessed in May 8. Available at

Geographic variations in cardiovascular health in the United States: contributions of state-and individual-level factors

Trends in major risk factors for cardiovascular disease among adults in the Mississippi Delta region, Mississippi Behavioral Risk Factor Surveillance System

American Community Survey (A.C.S.)

Evidence of a "heart failure belt" in the southeastern United States

Geographic distribution of diagnosed diabetes in the U.S.: a diabetes belt

Twenty Years of Progress Toward Understanding the Stroke Belt

Reducing Cardiovascular Disparities Through Community-Engaged Implementation Research: A National Heart, Lung, and Blood Institute Workshop Report

Clinical Characteristics of Coronavirus Disease 2019 in China

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response

Hospitalization and Mortality among Black Patients and White Patients with Covid-19

Genetic Susceptibility for COVID-19-Associated Sudden Cardiac Death in African Americans

Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations

Racial disparities in exposure, susceptibility, and access to health care in the US H1N1 influenza pandemic

Effect of race/ethnicity and socioeconomic status on pandemic H1N1-related outcomes in Massachusetts

Vital Signs: Racial Disparities in Age-Specific Mortality Among Blacks or African Americans -United States

Race, ethnicity and disasters in the United States: a review of the literature

The relation of residential segregation to all-cause mortality: a study in black and white

Implicit Racial/Ethnic Bias Among Health Care Professionals and Its Influence on Health Care Outcomes: A Systematic Review

Factors explaining excess stroke prevalence in the U

The geographic distribution of obesity in the U.S. and the potential regional differences in misreporting of obesity

Racial and geographic variation in coronary heart disease mortality trends. B.M.C. Public Health

Regional differences in diabetes as a possible contributor to the geographic disparity in stroke mortality: the REasons for Geographic And Racial Differences in Stroke Study

Geographic disparities in declining rates of heart disease mortality in the southern United States

Association Between Aging of the U.S. Population and Heart Disease Mortality From

Differences in Stroke Mortality Among Adults Aged 45 and Over: United States

Cardiovascular Health and Disease Among Asian-Americans (from the National Health and Nutrition Examination Survey)

Ideal Cardiovascular Health Among American Adults After the Economic Recession of

American Community Survey (ACS)

Changes in Cardiovascular Health in the United States

Status of cardiovascular health among adult Americans in the 50 States and the District of Columbia

Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity

Centers for Disease C and Prevention. Conclusion and future directions: CDC Health Disparities and Inequalities Report -United States

Centers for Disease C and Prevention. Introduction: CDC Health Disparities and Inequalities Report -United States

Racial/Ethnic Health Disparities Among Rural Adults -United States

Cardiovascular Health and Disease Among Asian-Americans (from the National Health and Nutrition Examination Survey)

Ideal Cardiovascular Health Among American Adults After the Economic Recession of

Awareness, Treatment, and Poor Control of Hypertension Among Young American Adults: Race-Stratified Analysis of the National Health and Nutrition Examination Survey

Increased awareness, inadequate treatment, and poor control of cardiovascular risk factors in American young adults

Testing and estimating model-adjusted effect-measure modification using marginal structural models and complex survey data

Comparisons of Estimates From the Behavioral Risk Factor Surveillance System and Other National Health Surveys

The behavioral risk factor surveys: II. Design, methods, and estimates from combined state data

Geographic variations in cardiovascular health in the United States: contributions of state-and individual-level factors

Trends in major risk factors for cardiovascular disease among adults in the Mississippi Delta region, Mississippi Behavioral Risk Factor Surveillance System

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan

Critical Care Utilization for the COVID-19

Early Experience and Forecast During an Emergency Response

We thank the Reviewer for their comments. At the time of the previous submission of the manuscript in May 2020, only 30 states were reporting the race-stratified COVID-19 case count and mortality data. Hence, only 30 states had been included in the study. In the updated manuscript, we now have 47 states with race-stratified COVID-19 case and mortality data. Consequently, we have included in the analysis of the correlation between state-level racestratified comorbidities and COVID-19 crude and IFR.

We thank the Reviewer for their comments. We have now removed the multiple graphs for the ease of the reference for the reader.

The ecological study design precluded us from formally assessing the relationship of individual components with COVID-19 mortality and IFR, as it may bias readers to derive inference at the individual level. Further investigation of patient-level data may help provide more granular J o u r n a l P r e -p r o o f insights into the race-stratified exposure-outcome relationship in COVID-19 patients. We now acknowledge this in our study limitations.Discussion, Page 16 "The ecological study design with no data on individual-level measurements among COVID-19 patients may be prone to ecological fallacies if conclusions are drawn at the individual level. Due to a lack of individual-level measures on comorbidities, preexisting conditions, poor health behaviors, and socioeconomic factors in COVID-19 patients, we were not able to assess a multivariable-adjusted relationship of the various race-stratified state-level measures. We did not assess the correlation of individual health determinants with COVID-19 mortality as it may lead to the ecological fallacy of the derivation of exposure-outcome inference at patient-level. Additionally, COVID-19 outcomes data are still accumulating and are lagging. As the understanding of the disease advances, the accuracy of our assumptions may be re-evaluated when further research examines individual-level data from COVID-19 patients."

Confidence intervals are not mentioned in this section. How were confidence intervals generated around prevalence calculations? Depending on the methods used, the Cis may be systematically conservative/anticonservative in size.

We thank the Reviewer for their comments. The confidence intervals are computed for the various measures reported in the study since the BRFSS survey is conducted in a sample of the total state population, and the survey design is such that each respondent may be differentially weighted with the overall sample being representative of the national/state-level demographic distribution. Furthermore, we provide age-standardized estimates of all the measures. The PROCSURVEY procedures in SAS 9.4 (Cary, NC) allows researchers to account for the complex survey sampling and to provide age-adjusted prevalence estimates. Since age is the most common and important confounder in health and behavioral studies, the National Center for Health Statistics recommends analysis and reporting of prevalence estimated after age-standardization. 12, 13 The methodological details of the procedures are available publically at the Centers for Disease Control and Prevention's NHANES Web-tutorial 12 and in other publications. [13] [14] [15] Methods, Page 6 "All statistical analyses were done using the survey procedures in SAS 9.4 (SAS Institute Inc., Cary, N.C) to account for the intricate stratified survey sampling design. 12 The national, regional, and state-level population estimates were generated using sample weights to account for participant non-response and non-coverage in the sample design. 16, 17 The race-stratified demographic and socioeconomic details of the study population were summarized. The 2010 U.S Census population proportions for the age-groups of [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] , ≥65 years were used to generate race-stratified age-standardized prevalence estimates for the biological, behavioral, and socioeconomic determinants of health. 12 The estimates were generated at the level of state and geographic region, as defined by the U.S. Census Bureau." J o u r n a l P r e -p r o o f 6. The authors excluded areas with unreliable estimates due to low population counts.

Response: We thank the Reviewer for their response. We excluded those individual states where the confidence interval for the age-adjusted race-stratified parameter estimates was crossing null. The parameters not reported were (seen in Black individuals only): 

Response: We thank the Reviewer for their comments. We had previously not formally assessed the race-stratified relationship of state-level measures from BRFSS with state-level COVID-19 crude mortality and IFR. Based on the Reviewer's suggestion, we evaluate and present the relationship of the health determinants with COVID-19 mortality and IFR.Methods, Page 7 "We assessed the correlation of the race-stratified state-level crude mortality rate and IFR, and the state-level, race-stratified, prevalence of various health determinants." 

Response: We thank the Reviewer for their comment. There were 623,177 COVID-19 cases of self-identified Black and 1,272,675 COVID-19 cases of White individuals in 47 states reporting race-stratified COVID-19 data as of August 16. There were 33,513 total deaths among Black individuals and 78,272 deaths among Whites. We have included these details in the Results section.

In the states reporting race-stratified data, there were total 623,177 COVID-19 cases among Black individuals and 1,272,675 cases among White individuals. There were 33,513 total deaths among Black individuals and 78,272 deaths among Whites." 2. It is unclear to this Reviewer why results for components of the 4 strata are presented in this section, but relationships with COVID-19 mortality rates are given solely at their aggregated strata level.

We thank the Reviewer for their suggestion. We agree with the Reviewer that the exposure-outcome relationship is of special interest, especially in the COVID-19 patients from respective racial groups. We did not have access to the patient-level data of the various comorbidities, preexisting medical conditions, poor health behaviors, and adverse socioeconomic factors in COVID-19 patients. In this ecological study, the lack of patient-level data precluded us from showing the relationship of population-level individual health determinant components with COVID-19 mortality. The presentation of such data may lead to a biased interpretation of the population-level data to the individual-level. Future investigations involving patient-level data may help provide more granular insights into the race-stratified exposure-outcome relationship in COVID-19 patients. We acknowledge this in our study limitations.Discussion, Page 17 "The ecological study design with no data on individual-level measurements among COVID-19 patients may be prone to ecological fallacies if conclusions are drawn at the individual level. Due to a lack of individual-level measures on comorbidities, preexisting conditions, poor health behaviors, and socioeconomic factors in COVID-19 patients, we were not able to assess a multivariable-adjusted relationship of the various race-stratified state-level measures. We did not assess the correlation of individual health determinants with COVID-19 mortality as it may lead to the ecological fallacy of the derivation of exposure-outcome inference at patient-level. Additionally, COVID-19 outcomes data are still accumulating and are lagging. As the understanding of the disease advances, the accuracy of our assumptions may be re-evaluated when further research examines individual-level data from COVID-19 patients."J o u r n a l P r e -p r o o f Discussion 1. What do the authors mean when they say, "known health determinants did not track with the current geographic pattern of COVID-19 fatality"? That there is not only no direct relationship, but also no inverse relationship? Response: We thank the Reviewer for their comments. The quoted statement aimed to highlight the lack of both direct and/or inverse correlation of the respective health determinants with COVID-19 mortality and IFR. While our data demonstrate a large regional and racial variability in the population prevalence of health determinants, we did not observe a significant increase or decrease in the COVID-19 mortality and IFR with the increase in the prevalence of health determinants.

Response: We thank the Reviewer for their comments. Numerous reports from inpatient settings from numerous international and national cohorts indicate higher COVID-19 mortality among individuals with greater comorbidity burden, having multiple coexisting illnesses, in the setting of socioeconomic factors. We clarify this statement in our Discussion section.Discussion, Page 13 "The population-level COVID-19 mortality burden is presumed to follow the population prevalence of comorbidities given that comorbidity burden and concomitant illnesses are critical factors in predicting the risk of fatal outcomes from COVID-19 in inpatient settings. 18-25 " 3. What does geographic stigmatization mean? A more detailed explanation would be helpful.

We thank the Reviewer for their comments. Geographic stigmatization was used to refer to the presumed stigma attached to individuals and the health conditions of the individuals living in a certain geographic region. The term was discussed in the context of reducing the associated bias accompanied with the planning and resource allocation to combat the problems of certain regions. We have now expunged the statement from the Discussion to avoid any confusion with the readers.

Response: We thank the Reviewer for their comments. We agree that while Hispanics are similarly weighted to Blacks in BRFSS at a national level, there are low population counts at individual state levels, making the majority of the age-adjusted prevalence estimates unreliable in a majority of states (>50%) with the confidence intervals crossing null. This was due to us J o u r n a l P r e -p r o o f using the state-level race-stratified age-standardization to generate age-standardized population prevalence estimates for he biological, behavioral, and socioeconomic determinants of health. 12 Moreover, the COVID-19 case and mortality data are incongruently reported across various state public health departments with missing Hispanic data in several states. Therefore adequate assessment could not be performed. We acknowledge these in our study limitations.Discussion, Page 16 "The small population size of other racial sub-groups at the state-level lead to unreliable estimates restricting their inclusion in the study. Moreover, due to several incongruences, lack of uniformity, and large missing data, in the reporting of race-stratified COVID-19 cumulative incidence and mortality reported by respective states, prevented us from making a uniform assessment." Response: We thank the Reviewer for their comment. We have rectified the error in our updated manuscript. Figure 1A and 1B are illegible and should be presented in an alternate manner for clarity.

J o u r n a l P r e -p r o o f 3. It appears that Figures 2 and 3 were how the authors determined no correlation between geographic distribution of health determinants and COVID-19 mortality, perhaps through fitting a statistic such as Pearson correlation coefficient or R-squared. First, they should make clear what they used to determine such a relationship and provide values of the statistic used if that is the case.

We thank the Reviewer for their comments. We now show the Pearson correlation coefficient for relationship of the race-stratified state-level measures (in aggregate strata and individually) with COVID-19 mortality and IFR. Table 1 , providing confidence intervals for socioeconomic/demographic data doesn't make sense in that there is no uncertainty associated with these survey variables.

Raw proportion frequencies not reflective of the state level race stratified population.

We thank the Reviewer for their comments. We provide age-standardized population estimates of the frequency of the particular measures accounting for the differential survey weighting and clustering of respondents. The differential weighting of the survey respondents to be representative of the state/region/national level population proportion and age-standardization introduces variability in the estimates to be representative of the sate/region/national population. It would be feasible to report the raw frequency of the demographic and socioeconomic characteristics but would indicate the frequency within the study survey sample and not reflective of the state or regional population.